Form 4: Akero Therapeutics CFO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
William Richard White, CFO of Akero Therapeutics, sold 2,831 shares of common stock on June 11, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On June 11, 2024, William Richard White, the Chief Financial Officer of Akero Therapeutics, Inc., sold 2,831 shares of the company's common stock.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- The shares were sold at a weighted-average price of $22.64, with individual transactions ranging from $22.50 to $22.76.
- Following the transaction, White directly owns 46,799 shares of Akero Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction for tax purposes and doesn't necessarily reflect a positive or negative outlook on the company.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes when restricted stock units vest.
Stakeholder Impact
- The sale has a minimal impact on shareholders as it is a small percentage of the outstanding shares and is related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/11/2024 | Date of the stock sale transaction. |
| 06/13/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.